Your email has been successfully added to our mailing list.

×
-0.00448979591836732 -0.0018367346938775 0.00257142857142855 0.00297959183673477 0.00812244897959187 0.00718367346938783 0.0113469387755102 0.0135510204081632
Stock impact report

Best Vascular/Novoste Celebrates 24th Anniversary of Vascular Brachytherapy Approval & Use of by US FDA [Yahoo! Finance]

Cardinal Health, Inc. (CAH) 
Last cardinal health, inc. earnings: 2/6 06:55 am Check Earnings Report
US:NYSE Investor Relations: ir.cardinalhealth.com/home
Company Research Source: Yahoo! Finance
clinical trials were performed and 24 years since the approval of VBT for human clinical use for the treatment of in-stent coronary artery restenosis by the US FDA on November 3, 2000. Dr. Paul Teirstein, at Scripps Clinic in La Jolla, California, in collaboration with Virginia-based Best Medical International (BMI), began the first randomized, double-blind human clinical trials Phase 1 study using Iridium-192 seeds in nylon ribbons starting in 1994. At approximately the same time, Dr. Ron Waksman, at Emory University in Atlanta, Georgia, in collaboration with BMI, was conducting animal experiments using Iridium-192 seeds in nylon ribbons. All the initial animal experiments and human clinical studies were conducted using BMI Iridium-192 seeds in nylon ribbons. The first Phase 1 study's successful clinical results were published at the first VBT meeting, hosted by Dr. Ron Waksman and Emory University, in January 1996 at the JW Marriott Hotel in Atlanta, Georgia. Subsequently, t Show less Read more
Impact Snapshot
Event Time:
CAH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CAH alerts
Opt-in for
CAH alerts

from News Quantified
Opt-in for
CAH alerts

from News Quantified